Low-dose azacitidine maintenance therapy after allogeneic stem cell transplantation for high-risk pediatric acute myeloid leukemia

被引：23

作者：

Tamura, Akihiro ^{[1
]}

Ishida, Toshiaki ^{[1
]}

Saito, Atsuro ^{[1
]}

Yamamoto, Nobuyuki ^{[1
]}

Yokoi, Takehito ^{[1
,2
]}

Uemura, Suguru ^{[1
,3
]}

Nino, Nanako ^{[1
,3
]}

Fujiwara, Takahiro ^{[1
]}

Tahara, Teppei ^{[1
]}

Nakamura, Sayaka ^{[1
]}

Kozaki, Aiko ^{[1
]}

Kishimoto, Kenji ^{[1
]}

Hasegawa, Daiichiro ^{[1
]}

Kosaka, Yoshiyuki ^{[1
]}

机构：

[1] Kobe Childrens Hosp, Childrens Canc Ctr, Dept Hematol & Oncol, Kobe, Hyogo, Japan

[2] Osaka Univ Hosp, Dept Pediat, Suita, Osaka, Japan

[3] Kobe Univ Hosp, Dept Pediat, Kobe, Hyogo, Japan

来源：

PEDIATRIC BLOOD & CANCER | 2018年 / 65卷 / 10期

关键词：

acute myeloid leukemia; azacitidine; pediatric; post hematopoietic stem cell transplantation; CONVENTIONAL CARE REGIMENS; REGULATORY T-CELLS; MYELODYSPLASTIC SYNDROME; HYPOMETHYLATING AGENT; ELDERLY-PATIENTS; SALVAGE THERAPY; 5-AZA-2'-DEOXYCYTIDINE; MALIGNANCIES; DECITABINE; RELAPSE;

D O I：

10.1002/pbc.27284

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The dismal prognosis of pediatric acute myeloid leukemia (AML) relapsing after hematopoietic stem cell transplantation (HSCT) requires exploration of novel strategies to prevent relapse. Azacitidine (AZA) maintenance therapy could potentially reduce the recurrence rate post HSCT. Here, we presents the cases of three children with high-risk AML post HSCT who were treated with low-dose AZA maintenance therapy, demonstrating the feasibility of this therapy. Currently, all three are in complete remission for 13-41 months despite their high-risk characteristics. Our encouraging data warrant larger prospective studies to assess the efficacy and safety of low-dose AZA maintenance therapy post HSCT for pediatric patients with high-risk AML.

引用

页数：4

共 16 条

[1] In vivo administration of hypomethylating agents mitigate graft-versus-host disease without sacrificing graft-versus-leukemia [J].

Choi, Jaebok ;

Ritchey, Julie ;

Prior, Julie L. ;

Holt, Matthew ;

Shannon, William D. ;

Deych, Elena ;

Piwnica-Worms, David R. ;

DiPersio, John F. .

BLOOD, 2010, 116 (01) :129-139

[2] Tolerability and Clinical Activity of Post-Transplantation Azacitidine in Patients Allografted for Acute Myeloid Leukemia Treated on the RICAZA Trial [J].

Craddock, Charles ;

Jilani, Nadira ;

Siddique, Shamyla ;

Yap, Christina ;

Khan, Josephine ;

Nagra, Sandeep ;

Ward, Janice ;

Ferguson, Paul ;

Hazlewood, Peter ;

Buka, Richard ;

Vyas, Paresh ;

Goodyear, Oliver ;

Tholouli, Eleni ;

Crawley, Charles ;

Russell, Nigel ;

Byrne, Jenny ;

Malladi, Ram ;

Snowden, John ;

Dennis, Mike .

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (02) :385-390

[3] Maintenance Therapy With Low-Dose Azacitidine After Allogeneic Hematopoietic Stem Cell Transplantation for Recurrent Acute Myelogenous Leukemia or Myelodysplastic Syndrome [J].

de Lima, Marcos ;

Giralt, Sergio ;

Thall, Peter F. ;

Silva, Leandro de Padua ;

Jones, Roy B. ;

Komanduri, Krishna ;

Braun, Thomas M. ;

Nguyen, Hoang Q. ;

Champlin, Richard ;

Garcia-Manero, Guillermo .

CANCER, 2010, 116 (23) :5420-5431

[4] Azacitidine Use After Allogeneic Stem Cell Transplantation-Results From the Polish Adult Leukemia Group [J].

Drozd-Sokotowska, J. ;

Gil, L. ;

Waszczuk-Gajda, A. ;

Madry, K. ;

Piekarska, A. ;

Dutka, M. ;

Basak, G. W. ;

Karakulska-Prystupiuk, E. ;

Dwilewicz-Trojaczel, J. .

TRANSPLANTATION PROCEEDINGS, 2016, 48 (05) :1802-1805

[5] Azacitidine Prolongs Overall Survival Compared With Conventional Care Regimens in Elderly Patients With Low Bone Marrow Blast Count Acute Myeloid Leukemia [J].

Fenaux, Pierre ;

Mufti, Ghulam J. ;

Hellstrom-Lindberg, Eva ;

Santini, Valeria ;

Gattermann, Norbert ;

Germing, Ulrich ;

Sanz, Guillermo ;

List, Alan F. ;

Gore, Steven ;

Seymour, John F. ;

Dombret, Herve ;

Backstrom, Jay ;

Zimmerman, Linda ;

McKenzie, David ;

Beach, C. L. ;

Silverman, Lewis R. .

JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (04) :562-569

[6] Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study [J].

Fenaux, Pierre ;

Mufti, Ghulam J. ;

Hellstrom-Lindberg, Eva ;

Santini, Valeria ;

Finelli, Carlo ;

Giagounidis, Aristoteles ;

Schoch, Robert ;

Gattermann, Norbert ;

Sanz, Guillermo ;

List, Alan ;

Gore, Steven D. ;

Seymour, John F. ;

Bennett, John M. ;

Byrd, John ;

Backstrom, Jay ;

Zimmerman, Linda ;

McKenzie, David ;

Beach, C. L. ;

Silverman, Lewis R. .

LANCET ONCOLOGY, 2009, 10 (03) :223-232

[7] The DNA methyltransferase inhibitors azacitidine, decitabine and zebularine exert differential effects on cancer gene expression in acute myeloid leukemia cells [J].

Flotho, C. ;

Claus, R. ;

Batz, C. ;

Schneider, M. ;

Sandrock, I. ;

Ihde, S. ;

Plass, C. ;

Niemeyer, C. M. ;

Luebbert, M. .

LEUKEMIA, 2009, 23 (06) :1019-1028

[8] 5-Azacytidine treatment sensitizes tumor cells to T-cell mediated cytotoxicity and modulates NK cells in patients with myeloid malignancies [J].

Gang, A. O. ;

Frosig, T. M. ;

Brimnes, M. K. ;

Lyngaa, R. ;

Treppendahl, M. B. ;

Gronbaek, K. ;

Dufva, I. H. ;

Straten, P. Thor ;

Hadrup, S. R. .

BLOOD CANCER JOURNAL, 2014, 4 :e197-e197

[9] Induction of a CD8+ T-cell response to the MAGE cancer testis antigen by combined treatment with azacitidine and sodium valproate in patients with acute myeloid leukemia and myelodysplasia [J].

Goodyear, Oliver ;

Agathanggelou, Angelo ;

Novitzky-Basso, Igor ;

Siddique, Shamyla ;

McSkeane, Tina ;

Ryan, Gordon ;

Vyas, Paresh ;

Cavenagh, Jamie ;

Stankovic, Tanja ;

Moss, Paul ;

Craddock, Charles .

BLOOD, 2010, 116 (11) :1908-1918

[10] Azacitidine augments expansion of regulatory T cells after allogeneic stem cell transplantation in patients with acute myeloid leukemia (AML) [J].

Goodyear, Oliver C. ;

Dennis, Mike ;

Jilani, Nadira Y. ;

Loke, Justin ;

Siddique, Shamyla ;

Ryan, Gordon ;

Nunnick, Jane ;

Khanum, Rahela ;

Raghavan, Manoj ;

Cook, Mark ;

Snowden, John A. ;

Griffiths, Mike ;

Russell, Nigel ;

Yin, John ;

Crawley, Charles ;

Cook, Gordon ;

Vyas, Paresh ;

Moss, Paul ;

Malladi, Ram ;

Craddock, Charles F. .

BLOOD, 2012, 119 (14) :3361-3369

← 1 2 →